Christchurch Regenerative Medicine and Tissue Engineering (CReATE) Group, New Zealand
Khoon has a BE (Hons1) in Chemical Engineering and both ME, PhD in Biomedical Engineering from the University of New South Wales, Australia. He has won several prestigious awards such as the UNSW Dean’s Award in Postgraduate Research and IEEE Technologies of the Future Competition. He is currently employed as a Postdoctoral Fellow in the Christchurch Regenerative Medicine and Tissue Engineering (CReATE) Group, New Zealand. His research activity focuses on using soft biomaterials (hydrogels) to deliver instructive elements that are capable of signalling cells down a pathway of tissue organisation and formation. This specific research will help bridge the gap between materials and science, improve the current tissue regeneration technology and solve the current problems faced with organ donation not only in NZ but worldwide. His research projects also involve several collaborations in Netherlands, Portugal, UK and Australia. He has authored several publications in most prestigious journals in Tissue Engineering and Regenerative Medicine.
Università Cattolica S. Cuore, Rome, Italy
Wanda Lattanzi, is an MD PhD, specialized in Medical Genetics, and. Her research activity focuses mostly on molecular and cellular bone biology, including the study of congenital bone malformations and the development of cell-based bone regeneration strategies. She has been involved in EU-FP7-funded projects and is currently coordinating research projects funded by the Italian Ministry of Health and the National Institutes of Health (USA). She is author of over 60 publications, including 37 peer-reviewed manuscripts, member of the Editorial board of diverse international journals and reviewers in national and international grant programs. She is appointed as a tenured Assistant Professor of Anatomy at the Università Cattolica S. Cuore (Rome, Italy), where she holds the Chair of Anatomy in diverse master degree courses. She is also appointed in the Medical Coordination Staff of the Latium Musculoskeletal Tissue Bank, where she coordinates bone tissue procurement, processing, banking and distribution.
Maastricht University, Maastricht, The Netherlands
Carlos is currently a postdoctoral research fellow at MERLN Institute for Technology-inspired Regenerative Medicine, Maastricht University. In 2013, he was a postdoc at the department of Tissue Regeneration, University of Twente, the Netherlands where he developed, in partnership with Screvo B.V., a multiwell array platform for high content screening, targeting the effect of small molecules and biopharmaceutical in cancer therapeutics in vitro and in vivo. Carlos received his PhD in Biomaterials from the BIOS research doctorate school in Biomolecular Sciences at the University of Pisa, in March 2012. His doctoral studies were focused on the development of new approaches for the fabrication of polymeric scaffolds for Tissue Engineering applications. Furthermore, he was a researcher at the department of Neurosciences, University of Pisa, where he developed scaffolds for otology surgery applications. Currently, his main research interests are focused on biofabrication, bioprinting and additive manufacturing techniques for the development of tissue engineered constructs.
Technical University of Lisbon, Lisbon, Portugal
Frederico holds a PhD in Chemical Engineering from Imperial College London and a MBA from the New University of Lisbon (UNL). He graduated in Applied Chemistry (minor in Biotechnology) in 1999 from UNL. From 2004 to 2006, he was research associate at Imperial College London in an Industrial Project with GlaxoSmithKline, and an Imperial College London’s honorary research associate from 2006 to 2010. He was a visiting researcher (July 2007) at Institut Européen des Membranes, Montpellier, and a visiting scholar (Set-Dec 2009) at Massachusetts Institute of Technology (MIT), Deshpande Center for Technological Innovation. His current research interests are (i) tailoring materials for stem cells applications, namely mimicking the natural extracellular micro environment using nanofiber based polymeric 3D matrices and developing stimulus responsive systems for stem cell ex-vivo cultivation, (ii) developing biorefinery based processes for sustainable production of biofuels and added value products, and (iii) design new hybrid systems for advanced purification of pharmaceutics, namely through membrane separations. He is a member of the BioEngineering Research Group at the Institute for Bioengineering and Biosciences. He teaches at the Department of Bioengineering at Instituto Superior Tecnico, Technical University of Lisbon, including the module, “Bioteams – teams for innovation” for MPP PhD students and launched two new elective PhD courses: “Materials for Regenerative Medicine” and “GoMed: New Ventures for Regenerative Medicine” He also assists CoHiTec on translation of technology to the market.
Ana Colette Maurício
University of Porto, Porto, Portugal
Ana has a degree on Veterinary Medicine since 1995, a PhD on Veterinary Sciences since 1999 from Faculdade de Medicina Veterinária (FMV) – Universidade Técnica de Lisboa (UTL) and Habilitation in Veterinary Sciences (ICBAS-UP) since 2011. The PhD experimental work was developed at Instituto Gulbenkian Ciência (IGC) in Oeiras, Portugal, at Freiburg Medicine Faculty in Germany and at Faculdade de Ciências e Tecnologia (FCT) from Universidade Nova de Lisboa (UNL). At the present, she is an Associated Professor with Habilitation, from the Veterinary Clinics of do Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), and she is the vice-President of the Pedagogic Council of ICBAS – UP. She also belongs to the Scientific Council of ICBAS-UP and to the Ethic Comission for Health Sciences from University of Porto (UP). She belongs to the Scientific Committee of the Veterinary Sciences Doctoral Program at ICBAS – UP. She is the Scientific Coordinator of Regenerative Medicine and Experimental Surgery sub-unit from Centro de Estudos de Ciência Animal (CECA) of Instituto de Ciências e Tecnologias Agrárias e Agro-Alimentares (ICETA), Universidade do Porto (UP). She is one of the founding shareholders of Biosckin, Molecular and Cell Therapies, S.A since 2007 with established scientific protocol with UP for development of new cell therapies and medical devices. For the past 12 years she coordinates a multidisciplinary research group of Experimental Surgery and Regenerative Medicine, working with several biomaterials and cellular therapies. She started working with embryonic stem cells obtained by somatic nuclear transfer for therapeutic use; with Ian Wilmut´s group (Dolly’s cloned sheep).
University of Minho, Guimarães, Portugal